SPHERA FUNDS MANAGEMENT LTD. - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$4,780,000
+32.9%
216,980
+8.5%
0.42%
+19.8%
Q3 2020$3,598,000
-55.7%
199,980
-64.6%
0.35%
-71.7%
Q3 2019$8,113,000
+63.7%
565,000
+79.6%
1.25%
+84.8%
Q2 2019$4,956,000
+70.2%
314,642
+78.0%
0.68%
+36.7%
Q4 2014$2,912,000176,8020.50%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,355,392$29,859,0006.21%
Bain Capital Life Sciences Investors, LLC 3,080,237$67,858,0004.26%
DAFNA Capital Management LLC 587,756$12,948,0003.85%
SILVERARC CAPITAL MANAGEMENT, LLC 227,388$5,009,0002.91%
RTW INVESTMENTS, LP 7,253,857$159,802,0002.68%
Parkman Healthcare Partners LLC 331,513$7,303,0001.87%
Evolutionary Tree Capital Management, LLC 60,864$1,341,0001.02%
Eagle Health Investments LP 69,000$1,520,0000.97%
Woodline Partners LP 1,358,796$29,934,0000.79%
Affinity Asset Advisors, LLC 40,000$881,0000.47%
View complete list of DICERNA PHARMACEUTICALS INC shareholders